VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2022

Feb 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2022-02-17

Reporting Person: LEIDEN JEFFREY M (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-17	Common Stock	F	8236	$232.51	Disposed	102090	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	440	Indirect